Synergy Pharmaceuticals Announces Extension for Filing of Third Quarter Form

Synergy Pharmaceuticals Announces Extension for Filing of Third Quarter Form

Filed under: drug addiction treatment act

9, 2012 (GLOBE NEWSWIRE) — Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that, in accordance with applicable rules issued by the United States Securities and …
Read more on NASDAQ

 

High court to take new look at voting rights law

Filed under: drug addiction treatment act

Should marijuana be treated like alcohol? Or should it remain in the same legal category as heroin and the most dangerous drugs? Votes this week by Colorado and Washington to …. Acting three days after the election, the justices agreed to hear a …
Read more on KTTC

 

SciClone Pharmaceuticals Management Discusses Q3 2012 Results – Earnings

Filed under: drug addiction treatment act

It is SciClone's intention that forward-looking statements regarding financial guidance and commercial and development activity made during today's call be protected under the Private Securities and Litigation Reform Act of 1995. Forward-looking …
Read more on Seeking Alpha